• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

acne

  1. WORKING AT SUN IS MISERABLE

    Doesn’t matter what division, it sucks. Let’s call it what it is, toxic, demoralizing, life suck place. Highest resignation #s in last year, home office should be embarrassed by but they blame people as disloyal traitors? Can’t wait to give my resignation, best Christmas gift ever for me & my...
    • anonymous
    • Thread
    • acne eyecare iluyma management oncology psoriasis sun biologics sun pharma
    • Replies: 35
    • Forum: Sun Pharma

  2. Dermira's fatal fall !

    https://news.alphastreet.com/dermira-suffers-a-fatal-fall-after-catastrophic-trial-fail/ Shares of the skin specialist tanked almost 60% on Monday after the company announced that its closely-watched experimental acne drug failed to meet the objectives of two phase 3 clinical trials.
    • anonymous
    • Thread
    • acne drugs fda stock
    • Replies: 1
    • Forum: Biotech Startups
Top Bottom
Back